Report highlights key progress and achievements across three pillars: access to medicines, R&D innovation, and product quality and patient safety 430,000 patients have been treated with Samsung Bioepis’ biosimilars across 40 countries in 2023 In 10 countries, our biosimilars have created social impact worth approximately 2.5 trillion KRW (1.9 billion USD) in 2023 The company [...]
SHANGHAI, June 25, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for toripalimab (product code: JS001) in [...]
RIO DE JANEIRO, June 25, 2024 (Korea Bizwire) – The third and final day of the FII PRIORITY Rio de Janeiro Summit concluded with pivotal discussions on global economic growth and sustainability. Organised by the FII Institute, the summit attracted nearly 1,500 global leaders, innovators, and entrepreneurs who participated in over 65 sessions. Delegates attended [...]
RIO DE JANEIRO, June 25, 2024 (Korea Bizwire) – The inaugural three-day Latin America FII PRIORITY Summit, powered by FII Institute, commenced on Tuesday at the Copacabana Palace Hotel in Rio de Janeiro. Convening global officials, along with business leaders from various sectors, the event will tackle pressing issues under the theme “Invest in Dignity.” [...]
Leather Manufacturer Prioritizes Quality & Customer Service Rochester Hills, MI, June 24, 2024 (Korea Bizwire) – Pangea is thrilled to announce that it has received the prestigious Certificate of Achievement in Quality Performance for 2023 from Toyota Motor Corporation (TMC). This esteemed award recognizes Pangea’s outstanding quality performance in supplying leather for several Toyota and [...]
London, UK, June 24, 2024 (Korea Bizwire) – OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine learning (ML) solutions provider that will work exclusively with OPEN Health. This alliance will see fusion’s market-leading AI capabilities deployed across OPEN Health’s [...]
Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member states of the Gulf Cooperation Council (GCC) and South Africa. EXBLIFEP® has been approved by the U.S. Food and Drug Administration (FDA) and the European Commission (EC) for the treatment of severe infections earlier in 2024. Saint-Louis, France and Weil am Rhein, Germany and Zurich, [...]
Treatment Costs Reduced by around 80% and Accelerated Access to Treatment RIYADH, Saudi Arabia, June 23, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSHRC) has successfully produced CAR T-cells internally for cancer treatment. This breakthrough has reduced the cost of treatment from 1.3 million SAR to approximately 250,000 SAR per treatment, [...]
BOSTON, June 22, 2024 (Korea Bizwire) – Novotech, a global full-service clinical Contract Research Organization (CRO) specializing in partnering with biotech companies to expedite the development of cutting-edge therapeutics across all phases, has today published a leading industry report, Liver Cancer – Global Clinical Trial Landscape. Liver cancer is the sixth most diagnosed cancer worldwide and the [...]
BOSTON, June 21, 2024 (Korea Bizwire) – Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has today released a key research whitepaper entitled Antibody-drug conjugates – Global Clinical Trial Landscape. Novotech’s whitepaper examines how the antibody-drug conjugates (ADCs), [...]